ASXIgnite Investment Summit Presentation
other announcement
PIQ
Pharmaceuticals, Biotechnology & Life Sciences
Proteomics International Laboratories
- Short interest
- 0.32%
- −0.31 pp 30d
- as of 14 Oct 2026
- Reported shorts
- 521.3K
- Shares on issue
- 165.373M
Proteomics International Laboratories (PIQ) News
Latest articles and price-sensitive announcements with AI sentiment classification.
PromarkerEndo Validation and Refinement Complete
other announcement
KalkineWhat could PIQ (ASX:PIQ) presentation reveal next?
Highlights Proteomics International has released a fresh market participant presentation as its diagnostic portfolio moves deeper into commercial rollout. The presentation comes against recent progress for PromarkerD and PromarkerEso, including their controlled release through an Australian pathology distribution arrangement. The latest update gives readers a consolidated view of the companys diagnostic platform, commercialisation pathway and upcoming development milestones. A fresh corp...
PromarkerD and PromarkerEso Commercial Rollout Update
other announcement
Google NewsProteomics International (ASX:PIQ) Advances Diagnostics Commercialisation Strategy Through Promarker Platform - Kalkine
Proteomics International (ASX:PIQ) Advances Diagnostics Commercialisation Strategy Through Promarker Platform Kalkine
Appendix 4G and Corporate Governance Statement
other announcement
Proteomics secures Australian patent for endometriosis test
Proteomics International has locked in a key Australian patent for its PromarkerEndo test, a significant step in its global commercialisation strategy for the endometriosis diagnostic.
Small CapsProteomics International (ASX:PIQ) Faces Funding Test as PromarkerD Advances - Kalkine
Proteomics International (ASX:PIQ) Faces Funding Test as PromarkerD Advances Kalkine
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
Webinar Presentation - Healius distribution agreement
other announcement
Proteomics taps Healius network for national diagnostics rollout
Proteomics International Laboratories has signed Healius as exclusive Australian pathology distributor for its Promarker blood tests, unlocking a network of more than 2000 collection centres.
Proteomics signs national distribution deal with Healius
other announcement
Why Is Proteomics International (ASX:PIQ) Expanding Its ASX Share Capital?
Highlights Proteomics International has applied to quote additional ordinary shares on the ASX following the exercise of existing equity instruments. The newly quoted shares modestly expand the company's issued capital while supporting normal capital management activities. The latest update reflects continued utilisation of equity-based securities as the biotechnology company advances its commercial strategy. Proteomics International Laboratories Ltd (ASX:PIQ) has ann...
Proteomics bags US patent for endometriosis test
Proteomics International Laboratories has won a US patent for its endometriosis test, advancing plans to roll out the diagnostic product in the world’s biggest healthcare market.
Is Proteomics International (ASX:PIQ) Making a Comeback After Today's Rally? - Kalkine
Is Proteomics International (ASX:PIQ) Making a Comeback After Today's Rally? Kalkine
Proteomics International (ASX: PIQ) Skyrockets: What's Driving Today's Massive Rally? - Kalkine
Proteomics International (ASX: PIQ) Skyrockets: What's Driving Today's Massive Rally? Kalkine
Restructure, Executive Appointment and Board Update
other announcement
Here's Why We're Watching Proteomics International Laboratories' (ASX:PIQ) Cash Burn Situation - simplywall.st
Here's Why We're Watching Proteomics International Laboratories' (ASX:PIQ) Cash Burn Situation simplywall.st
Canadian patent secured for PromarkerEso test for EAC
other announcement
Proteomics US lab CAP accredited - extends precision Dx lab
other announcement
US patent secured for PromarkerEso diagnostic test for EAC
other announcement
PromarkerD changes how Doctors manage DKD - study published
other announcement
PromarkerD predicts risk of DKD in Aboriginal Australians
other announcement
US Medicare sets reimbursement price for PromarkerD DKD test
other announcement
Change of Director's Interest Notice x3
director_dealing announcement
OxiDx test correlates with superior racehorse performance
other announcement